Plexus Corp. PLXS
263.09
1.48
0.57%
as of 25 Sep
- Market cap
- $7.0B
- P/E
- 38.0×
Follow PLXS
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
43.45 | 29.02 | 22.41 | 22.61 |
+8 more quarters Free account |
P/S ratio |
1.75 | 1.26 | 0.95 | 0.97 | |
P/FCF ratio |
129.81 | 71.50 | 51.58 | 25.41 | |
P/Operating CF |
310.00 | 190.41 | (255.81) | 29.63 | |
P/B ratio |
5.25 | 3.64 | 2.66 | 2.69 | |
Price to Tangible BV |
5.28 | 3.66 | 2.67 | 2.70 | |
EV/Sales |
1.74 | 1.24 | 0.93 | 0.93 | |
EV/EBITDA |
26.01 | 17.81 | 13.36 | 13.36 | |
EV/Operating CF |
46.74 | 31.11 | 21.33 | 15.02 | |
EV/FCF |
129.18 | 70.59 | 50.38 | 24.31 | |
Quick Ratio |
0.57 | 0.59 | 0.60 | 0.63 | |
Current Ratio |
1.49 | 1.54 | 1.59 | 1.58 | |
Net Debt/EBITDA |
(0.49) | (0.85) | (1.24) | (2.33) | |
Debt/Assets |
7.58% | 6.97% | 4.96% | 4.39% | |
Debt/Equity |
0.18 | 0.16 | 0.11 | 0.09 | |
Asset Turnover |
1.36 | 1.34 | 1.32 | 1.28 | |
Operating CF/Net income |
0.60 | 0.57 | (0.37) | 2.57 | |
Capex/Depreciation |
(1.41) | (0.65) | (1.83) | (1.81) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
5.37% | 4.93% | 4.83% | 4.88% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
1.62% | 0.68% | 0.73% | 0.74% | |
Graham Net Nets |
0.10 | 0.14 | 0.19 | 0.18 | |
Graham Number |
94.40 | 93.51 | 90.37 | 88.02 | |
Earnings Yield |
2.30% | 3.45% | 4.46% | 4.42% | |
Free Cash Flow Yield |
0.77% | 1.40% | 1.94% | 3.94% | |
Revenue per Share |
48.85 | 43.49 | 39.97 | 39.14 | |
Operating CF per Share |
0.97 | 1.06 | (0.57) | 4.88 | |
Capex per Share |
(1.00) | (0.47) | (1.31) | (1.29) | |
Free Cash Flow per Share |
(0.03) | 0.60 | (1.89) | 3.59 | |
Cash per Share |
11.78 | 11.33 | 9.32 | 11.35 | |
Shareholders Equity per Share |
57.23 | 55.68 | 55.33 | 53.80 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
57.23 | 55.68 | 55.33 | 53.80 | |
Free Cash Flow |
(0.75) | 16.01 | (50.58) | 97.20 | |
Working Capital |
949.58 | 924.92 | 913.01 | 880.11 | |
Capital Expenditures |
(26.66) | (12.45) | (35.19) | (34.82) | |
Net Current Asset Value |
790.50 | 766.03 | 751.73 | 716.27 | |
EV/EBIT |
34.65 | 23.99 | 18.30 | 18.50 | |
Capex to Sales |
0.02 | 0.01 | 0.03 | 0.03 | |
Net Profit Margin |
3.30% | 4.28% | 3.85% | 4.86% | |
Price to Operating Income |
34.82 | 24.30 | 18.74 | 19.33 | |
| Other line items | |||||
Average Receivables |
729.35 | 655.92 | 638.57 | 639.47 | |
Average Payables |
850.58 | 765.99 | 705.88 | 666.49 | |
Average Inventory |
1,383.31 | 1,327.06 | 1,297.76 | 1,270.64 | |
Average Assets |
3,369.62 | 3,223.35 | 3,128.64 | 3,145.47 | |
Average Common Equity |
1,473.92 | 1,420.74 | 1,400.07 | 1,389.71 |
Columns are period end dates